China · Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 39.94 billion. The enterprise value is 38.19 billion.
| Market Cap | 39.94B |
| Enterprise Value | 38.19B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | May 14, 2026 |
Share Statistics
APT Medical has 139.23 million shares outstanding. The number of shares has decreased by -1.05% in one year.
| Current Share Class | 139.23M |
| Shares Outstanding | 139.23M |
| Shares Change (YoY) | -1.05% |
| Shares Change (QoQ) | -3.23% |
| Owned by Insiders (%) | 18.81% |
| Owned by Institutions (%) | 31.08% |
| Float | 73.50M |
Valuation Ratios
The trailing PE ratio is 39.55 and the forward PE ratio is 32.31.
| PE Ratio | 39.55 |
| Forward PE | 32.31 |
| PS Ratio | 12.99 |
| PB Ratio | 11.80 |
| P/TBV Ratio | 13.52 |
| P/FCF Ratio | 37.64 |
| P/OCF Ratio | 32.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.66, with an EV/FCF ratio of 36.00.
| EV / Earnings | 37.61 |
| EV / Sales | 12.42 |
| EV / EBITDA | 30.66 |
| EV / EBIT | 34.14 |
| EV / FCF | 36.00 |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.47 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 806.69 |
Financial Efficiency
Return on equity (ROE) is 30.97% and return on invested capital (ROIC) is 57.42%.
| Return on Equity (ROE) | 30.97% |
| Return on Assets (ROA) | 18.69% |
| Return on Invested Capital (ROIC) | 57.42% |
| Return on Capital Employed (ROCE) | 32.15% |
| Weighted Average Cost of Capital (WACC) | 2.42% |
| Revenue Per Employee | 986,049 |
| Profits Per Employee | 325,704 |
| Employee Count | 3,401 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, APT Medical has paid 163.95 million in taxes.
| Income Tax | 163.95M |
| Effective Tax Rate | 14.10% |
Stock Price Statistics
The stock price has increased by +0.61% in the last 52 weeks. The beta is -0.33, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +0.61% |
| 50-Day Moving Average | 255.99 |
| 200-Day Moving Average | 233.65 |
| Relative Strength Index (RSI) | 64.72 |
| Average Volume (20 Days) | 1,761,087 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 3.07 billion and earned 1.02 billion in profits. Earnings per share was 7.25.
| Revenue | 3.07B |
| Gross Profit | 2.24B |
| Operating Income | 1.12B |
| Pretax Income | 1.16B |
| Net Income | 1.02B |
| EBITDA | 1.24B |
| EBIT | 1.12B |
| Earnings Per Share (EPS) | 7.25 |
Balance Sheet
The company has 1.79 billion in cash and 11.99 million in debt, with a net cash position of 1.78 billion or 12.76 per share.
| Cash & Cash Equivalents | 1.79B |
| Total Debt | 11.99M |
| Net Cash | 1.78B |
| Net Cash Per Share | 12.76 |
| Equity (Book Value) | 3.41B |
| Book Value Per Share | 24.31 |
| Working Capital | 1.88B |
Cash Flow
In the last 12 months, operating cash flow was 1.24 billion and capital expenditures -178.92 million, giving a free cash flow of 1.06 billion.
| Operating Cash Flow | 1.24B |
| Capital Expenditures | -178.92M |
| Depreciation & Amortization | 117.79M |
| Net Borrowing | 357,195 |
| Free Cash Flow | 1.06B |
| FCF Per Share | 7.62 |
Margins
Gross margin is 72.79%, with operating and profit margins of 36.38% and 33.03%.
| Gross Margin | 72.79% |
| Operating Margin | 36.38% |
| Pretax Margin | 37.83% |
| Profit Margin | 33.03% |
| EBITDA Margin | 40.21% |
| EBIT Margin | 36.38% |
| FCF Margin | 34.51% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | -42.86% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 13.71% |
| FCF Payout Ratio | 13.12% |
| Buyback Yield | 1.05% |
| Shareholder Yield | 1.40% |
| Earnings Yield | 2.53% |
| FCF Yield | 2.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for APT Medical is 352.74, which is 22.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 352.74 |
| Price Target Difference | 22.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 25.14% |
| EPS Growth Forecast (3Y) | 28.09% |
Stock Splits
The last stock split was on June 19, 2025. It was a forward split with a ratio of 1.45.
| Last Split Date | Jun 19, 2025 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 36.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 36.7 |
| Piotroski F-Score | 6 |